Asia-Pacific myocardial infarction market is estimated to grow at the fastest CAGR of around 7.3% during the forecast period. Increasing cases related to CVD and heart attack, increasing healthcare infrastructure, and increasing unhealthy lifestyles among people in the region are some of the major factors for the growth of the market in Asia-Pacific. Moreover, increasing medical tourism and improving healthcare infrastructure are also contributing significantly to the growth of the myocardial infarction market in the region. The region provides future opportunities for growth as the demand for myocardial infarction treatment is continuously increasing in emerging economies such as India and China due to increasing cardiovascular disorders. According to the WHO, CVD causes one-third of the total fatalities each year in China. The rising geriatric population and associated prevalence of the chronic disease in them continue to spur the demand for myocardial infarction diagnosis and treatment.
Get Free Sample link @ https://www.omrglobal.com/request-sample/asia-pacific-myocardial-infarction-market
The market is segmented into type, device, diagnosis, treatment, and end-user. Based on type, the market is segmented into ST-elevation myocardial infarction (STEMI) heart attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and silent heart attacks. Based on the device, the market is segmented into a left ventricular assist device, pacemaker, implantable cardioverter defibrillator, and others (aspiration-based catheters). Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs), and research institutes.
A full report of Asia-Pacific Myocardial Infarction Market available @ https://www.omrglobal.com/industry-reports/asia-pacific-myocardial-infarction-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Asia-Pacific Myocardial Infarction Market by Type
- Non-ST-elevation myocardial infarction (NSTEMI)
- ST-elevation myocardial infarction (STEMI)
- Silent Heart Attacks
Asia-Pacific Myocardial Infarction Market by Device
- Left Ventricular Assist Device (LVAD)
- Pacemaker
- Catheters
- Implantable Cardioverter-Defibrillator (ICD)
- Others (Stent Graft)
Asia-Pacific Myocardial Infarction Market by Diagnosis
- Electrocardiography (ECG)
- Chest X-Ray
- Computed Tomography (CT Scan)
- Echocardiography
- Others (Blood Test)
Asia-Pacific Myocardial Infarction Market by Treatment
- Medication
- Analgesics
- Thrombolytic
- Antiplatelet Agents
- Glycoprotein IIb/IIIa Inhibitors
- Others (Beta-Adrenergic Blockers)
- Surgery
- Angioplasty
- Bypass Surgery
- Heart Transplant
Asia-Pacific Myocardial Infarction Market by End-User
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
Regional Analysis
- China
- Japan
- India
- Rest of Asia-Pacific
Company Profiles
- Abbott Laboratories Inc.
- AstraZeneca PLC
- Bayer AG
- Boston Scientific Corp.
- Bristol-Myers Squibb Co.
- CSL Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Johnson & Johnson Services, Inc.
- Medtronic PLC
- Merck KGaA
- Mesoblast Ltd.
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
- Siemens AG
The Report Covers
- Comprehensive research methodology of the Asia-Pacific myocardial infarction market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Asia-Pacific myocardial infarction market.
- Insights about market determinants which are stimulating the Asia-Pacific myocardial infarction market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-myocardial-infarction-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
